Tacrolimus Market to Incur Meteoric Growth During 2018-2026

Tacrolimus Market

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection. Tacrolimus inhibits the activation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This suppresses T lymphocyte activation and the subsequent generation of cytotoxic lymphocytes, thereby suppressing processes leading to organ rejection. Tacrolimus is primary immunosuppression drug used in kidney and liver transplant patients. Organ transplanted patients often require lifelong treatment with immunosuppressant. Major applications of this includes in cardiac transplant rejection, liver transplant rejection, kidney transplant rejection, and lung transplant immunosuppression treatment. Tacrolimus is available in various dosage forms such as tablets, capsules, and injections.

Tacrolimus Market Drivers

Tacrolimus is majorly used as an immunosuppressant after organ transplant procedures. Advancement in organ transplant procedures is a major factor expected to increase the number of organ transplants, which in turn is expected to boost global tacrolimus market growth over the forecast period. For instance, new methods are being researched to match more donor organs with patients such as stem cell studies, trophic factor studies, and natural models. As the need for organ transplantation increases and the waiting list continues to grow, successful utilization and transplantation of as many available donor organs as possible has become important. According to Organ Procurement and Transplantation Network (OPTN) 117,000+ number of men, women, and children are on the national transplant waiting list as of July 2017 in the U.S. and 17,155 organ transplants are done so far in 2017.

Moreover, according to National Kidney Foundation as of 2016, 121,678 people are waiting for lifesaving organ transplants in the U.S., of which 100,791 people are waiting for kidney transplants. Moreover, organ transplantation procedures have evolved with increase in feasibility and better understanding of immunology, which has allowed for improved matching rates for organs and patients after transplants. This is expected to result in increasing number of organ transplants which is expected to support the global tacrolimus market growth over the forecast period.

Certain side effects (malignancy, Psychosis, and others) of tacrolimus, although not significant, may hamper the global tacrolimus market growth. However, major growth limiting factor is expected to be significant gap between demand and supply of transplant organs, which indirectly could affect the global tacrolimus market growth.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2298

Tacrolimus Market Regional Analysis

North America tacrolimus market is expected to dominate over the forecast period. Presence of leading manufacturers as well as high number of organ transplant procedures is expected to support global tacrolimus market growth. Regional generic manufacturers are focusing on providing generic version of tacrolimus formulations in developed as well emerging economies. For instance, Strides Arcolab received the U.S. Food & Drug Administration (FDA) approval for tacrolimus capsules to be used as immuno-suppressant in 2014. Sandoz launched Tacrolimus, a generic version of Astellas’s PROGRAF (tacrolimus) in Japan, in 2015. Moreover, The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization for tacrolimus’ generic, Tacforius in 2017. These factors have supported the global tacrolimus market growth.

Tacrolimus Market Key Players

Key players operating in the global tacrolimus market include GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Mylan N.V., Astellas Pharma, Inc., Takeda Pharmaceuticals Company Ltd, Senju Pharmaceutical Co. Ltd., Guike Pharmaceutical Co. Ltd., DR. Reddy’s Laboratories Ltd., and Glenmark Pharmaceuticals Ltd.

Tacrolimus Market Taxonomy:

The global tacrolimus market is segmented on the basis of product type, application, end user, and region

By Product Type:

Tacrolimus Capsules and Tablets
Tacrolimus Ointment
Tacrolimus Injection

By Application:

Immunosuppression
Dermatitis
Others

By End User:

Organ Transplant Centers
Hospitals
Clinics

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments

Post a Comment

Popular posts from this blog

Breast Pumps Market Surge in Demand from Healthcare Industry to Boost Growth Forecast to 2026

Image
Breast pump devices enable women to express breast milk and store it for later use. These are especially useful for working mothers nursing a newborn. Breast pumps gaining eligibility for reimbursement under the Affordable Care Act is a key trend promoting its adoption in the U.S. Working mothers usually prefer automatic electronic breast pumps. These automatic breast pumps have adjustable suction level and variable cycling time, which offers enhanced comfort to the use. Double pumps help reduce pumping time as they drain both breasts simultaneously and more effectively. Market Dynamics Increasing awareness and favorable reimbursement policies are augmenting market growth. Growing number of women in the workforce is a major factor driving demand for breast pumps. Electric breast pumps which can express more milk in a shorter time are most popular among consumers in developed economies such as the U.S. and countries in Western Europe. However, the device is not...
Read more

Booms and Busts in Anatomic Pathology Market; Dynamics Trends Over The Time Discussed 2018-2026

Image
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples. Commercially available products include tissue processing systems, microtomes, cryostats, ...
Read more

Negative Pressure Wound Therapy (NPWT) Devices Market Outlook and Opportunities in Grooming Regions 2026

Image
Treatment options for wounds includes application of topical medication, sutures, staples, adhesives, compression therapy, hyperbaric oxygen therapy, biological dressings, and negative pressure wound therapy (NPWT). Negative pressure wound therapy, also called vacuum-assisted wound closure, has gained significant traction over the last decade as it is equally effective in acute and chronic wounds. NPWT is a relatively non-invasive wound therapy and offers various pips other conventional treatment options by facilitating better healing, shorter hospital stay, and fewer wound infections. Get Exclusive Sample Report at: http://bit.ly/30lpsDC Market Dynamics The primary benefits of NPWT such as elimination of edema, providing a moist wound-healing environment, and stimulating angiogenesis and blood flow to the wound is increasing its uptake. Moreover, the new guidelines outlined by the World Health Organization (WHO) in November 2016, recommends use of NPWT in...
Read more